News summary

Midlife Growth Hormone Receptor Ablation Modestly Slows Aging in Mice

Source: Fight Aging! • Published: 14 Sept 2026, 18:25

Summarized by Masters of Longevity from Fight Aging!.

A mouse-research feature outlining a midlife genetic manipulation study that assesses effects on aging, health measures, and liver cell gene programs.

Midlife Growth Hormone Receptor Ablation Modestly Slows Aging in Mice
Key Takeaways
  • A tamoxifen-inducible growth hormone receptor knockout at 12 months produced classical GH resistance with lower circulating IGF-1 and higher GH levels in mice.
  • Midlife Ghr ablation modestly extended lifespan under study conditions and improved male insulin sensitivity and neuromuscular and bone measures.
  • Single-nucleus RNA-seq of livers showed reduced B-cell abundance and sex-dimorphic transcriptional remodeling, including feminized gene programs in male hepatocytes.
Read the full article at Fight Aging!

Continue exploring

Recommended MoL Picks

MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.